ArticlePolymers2022
Influence of Parameters and Performance Evaluation of 3D-Printed Tungsten Mixed Filament Shields.
Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
- Article
- Retrospective analysis and IMRT replanning of a 3D-CRT murine dose painting study for preclinical oxygen-guided radiotherapy.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Currently, protective clothing used in clinical field is the most representative example of efforts to reduce radiation exposure to radiation workers. However, lead is classified as a substance harmful to the human body that can cause lead poisoning. Therefore, research on the development of lead-free radiation shielding bodies is being conducted. In this study, the shielding body was manufactured by changing the size, layer, and height of the nozzle, using a 90.7% pure tungsten filament, a 3D printer material, and we compared its performance with existing protection tools. Our findings revealed that the shielding rate of the mixed tungsten filament was higher than that of the existing protective tools, confirming its potency to replace lead as the most protective material in clinical field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.